Last updated on April 2019

S-CEI of Nexium in Paediatric Patients

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Gastroesophageal Reflux | Peptic Ulcer
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients aged 1(inclusive) to 15 (exclusive) years
  • Patients who have been prescribed Nexium for the first time for "gastric ulcer", "duodenal ulcer", "anastomotic ulcer", "reflux oesophagitis", "non-erosive reflux disease", or "Zollinger-Ellison syndrome", .

Exclusion Criteria:

  • Patients with a history of hypersensitivity to components contained in this product.
  • Patients during treatment with Atazanavir Sulfate and Rilpivirine hydrochloride.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.